Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease

Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds

(2015) Clifford W. Fong   JOURNAL OF MEMBRANE BIOLOGY

Pharmacokinetics, placenta, and brain uptake of paclitaxel in pregnant rats

(2014) Na-Young Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The blood-brain barrier: Structure, function and therapeutic approaches to cross it

(2014) Marta Tajes et al.   MOLECULAR MEMBRANE BIOLOGY

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss

(2013) Dae-Yong Song et al.   BMC NEUROSCIENCE

New perspectives on the pathophysiology of Parkinson’s disease as assessed by saccade performance: A clinical review

(2013) Yasuo Terao et al.   CLINICAL NEUROPHYSIOLOGY

Medicinal Chemistry Based Approaches and Nanotechnology-Based Systems to Improve CNS Drug Targeting and Delivery

(2012) Patrick Vlieghe et al.   MEDICINAL RESEARCH REVIEWS

Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys

(2008) Rosa M. Villalba et al.   EXPERIMENTAL NEUROLOGY

Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression

(2007) Dae Y. Song et al.   EXPERIMENTAL NEUROLOGY